| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $860K | +68.6% |
| Cost of Revenue | $643K | +78.1% |
| Gross Profit | $217K | +45.6% |
| R&D Expense | $19K | -5.0% |
| SG&A Expense | $3.5M | +9.2% |
| Operating Income | -$3.3M | -7.4% |
| Pre-tax Income | -$1.5M | +26.2% |
| Income Tax | $0 | — |
| Net Income | -$1.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.0M | -32.0% |
| Accounts Receivable | $89K | -52.2% |
| Inventory | $70K | +180.0% |
| Current Assets | $16.1M | -29.3% |
| Total Assets | $30.4M | -4.5% |
| Current Liabilities | $1.3M | +266.3% |
| Total Liabilities | $1.3M | +1.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +11.9% |
| Investing Cash Flow | -$1.7M | -121.2% |
| +26.2% |
| EPS (Basic) | $0.00 | — |
| Stockholders' Equity |
| $29.1M |
| -4.7% |